ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 664 • 2016 ACR/ARHP Annual Meeting

    Regulation of Interferon Signaling By a Calcium-Induced miRNA in Primary Human Salivary Gland Epithelial Cells

    Shyh-Ing Jang, NIDCR, NIH, Bethesda, MD

    Background/Purpose: Sjögren's syndrome (SS), an autoimmune disease that targets the salivary and lacrimal glands which causes dry eyes (xerophthalmia) and dry mouth (xerostomia) phenotypes. In…
  • Abstract Number: 665 • 2016 ACR/ARHP Annual Meeting

    Salivary Gland Secretome: A Novel Tool to Identify Biomarkers of Dryness and Immunopathology in Primary Sjogren’s Syndrome and Non-Autoimmune Sicca Patients

    Sofie L.M. Blokland1,2, Maarten R. Hillen1,2, Aike A. Kruize3, Timothy R.D.J. Radstake1,2 and Joel A.G. van Roon1,2, 1Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, UMC Utrecht, Utrecht, Netherlands, 3Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Salivary gland biopsy is essential in primary Sjögren’s syndrome (pSS) diagnostics. However, tissue analysis using the traditional method has several limitations including inaccuracy of quantification of lymphocytic infiltration and poor correlation with dryness.…
  • Abstract Number: 666 • 2016 ACR/ARHP Annual Meeting

    Immunoglobulin N-Glycosylation Acquired By Somatic Hypermutation As a Potential Mechanism for Non-Specific B Cell Activation in Sjogren’s Syndrome

    Kristi A. Koelsch1,2,3, Joshua Cavett4,5, Jacen Maier-Moore6, Kenneth Smith5, Christopher Lessard4,7,8, Lida Radfar9, David M. Lewis10, Biji T Kurien1,4,5, Astrid Rasmussen7, Kathy Sivils5,8, Judith A. James4,7,8, A. Darise Farris7 and R. Hal Scofield1,7,11, 1U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okalahoma City, OK, 3Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Dept. of Clinical Laboratory Science, University of Texas at El Paso, El Paso, TX, 7Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 8Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 9Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 10Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 11College of Medicine, Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration of the salivary and lacrimal glands resulting in tissue destruction, pathological dry…
  • Abstract Number: 667 • 2016 ACR/ARHP Annual Meeting

    Cytokine and Chemokine Levels in Serum and Saliva As Disease Activity Biomarkers in Patients with Primary Sjögren’s Syndrome

    Angel Tzec-Pérez1, Rosa Elda Barbosa-Cobos2, Gustavo Esteban Lugo-Zamudio3 and Lizbeth Teresa Becerril-Mendoza2, 1Hospital Juárez de México, Mexico city, Mexico, 2Rheumatology, Hospital Juárez de México, Mexico, Mexico, 3Rheumatology, Hospital Juárez de México, México, Mexico

    Background/Purpose: Background Evidence suggests that levels of different cytokines in primary Sjögren's syndrome (pSS) are associated with cell infiltration degree within salivary and lacrimal glands…
  • Abstract Number: 668 • 2016 ACR/ARHP Annual Meeting

    The TNFAIP3 F127C Coding Variation in Sjogren’s Syndrome: Results from a Greek Cohort

    Adrianos Nezos1, Theodora Gioka2, Michael Koutsilieris3, Michael Voulgarelis4, Athanasios G Tzioufas5 and Clio P. Mavragani3, 1Physiology, Department of Physiology, School of Medicine, National Kapodistrian University of Athens, Athens, Greece, 2Department of Physiology, School of Medicine, National Kapodistrian University of Athens, Athens, Greece, Athens, Greece, 3Department of Physiology, School of Medicine, National Kapodistrian University of Athens, Athens, Greece, 4Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 5Department of Pathophysiology, Department of Pathophysiology, School of Medicine, University of Athens, Greece, Athens, Greece

    Background/Purpose:  TNFAIP3 gene encodes the A20 protein which is an important negative feedback regulator of the NF-κB pathway. A coding TNFAIP3 polymorphism, namely rs2230926, has…
  • Abstract Number: 669 • 2016 ACR/ARHP Annual Meeting

    RNA-Sequencing Reveals Sjogren’s Syndrome Anti-Ro Negative Patients Share Similar Pathways to Multiple Sclerosis Patients

    Indra Adrianto1, John Ice1, Astrid Rasmussen2, Courtney Montgomery1, R. Hal Scofield1, Gabriel Pardo1, Kathy Sivils1, Robert Axtell1 and Christopher Lessard1, 1Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, USA, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is an autoimmune disease characterized by autoantibodies to Ro and/or La proteins and lymphocytic infiltration into exocrine glands. Multiple sclerosis (MS)…
  • Abstract Number: 670 • 2016 ACR/ARHP Annual Meeting

    Identification and Characterization of Sjogren’s Syndrome-Associated Genetic Variants in the IL12A and DDX6-CXCR5 Loci

    Michelle L. Joachims1, Indra Adrianto2, Audrey Johnston2, John Ice2, Astrid Rasmussen3, Simon Bowman4, David M. Lewis5, Lida Radfar6, Roald Omdal7, Marie Wahren-Herlenius8, Ilias Alevizos9, Torsten Witte10, Roland Jonsson11,12, Maureen Rischmueller13,14, Patrick M. Gaffney2, Judith A. James2,15,16, Lars Rönnblom17, Elke Theander18, Nelson L. Rhodus19, Barbara M. Segal20, R. Hal Scofield2,16,21, Courtney G. Montgomery2, Xavier Mariette22, Wan-Fai Ng23, Gunnel Nordmark24, Kathy L. Sivils2,15 and Christopher J. Lessard2,15, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, USA, Oklahoma City, OK, 4Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom, 5Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 6Oral Diagnosis and Radiology Department, University of Oklahoma College of Dentistry, Oklahoma City, OK, 7Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 8Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 9Sjögren's Syndrome Clinic, National Institute of Dental and Craniofacial Research, Bethesda, MD, 10Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, 11Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 12Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, 13Rheumatology, Queen Elizabeth Hospital, Adelaide, Australia, 14Rheumatology, University of Adelaide, Adelaide, Australia, 15Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 16Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 17Uppsala University, Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala, Sweden, 18Department of Rheumatology, Malmö University Hospital, Lund University, Sweden, Malmö, Sweden, 19Department of Diagnostic and Biological Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 20Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, 21US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 22Institut National de la Santé et de la Recherche Médicale, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, Paris, France, 23Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 24Rheumatology, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden

    Background/Purpose:  Sjögren’s syndrome (SS) is an autoimmune-mediated disease with hallmark features of dry eyes/mouth and autoantibodies. Genetic susceptibility to SS involves many loci, including the…
  • Abstract Number: 671 • 2016 ACR/ARHP Annual Meeting

    Steered Screening for Sjögren Syndrome in Patients with Sicca Syndrome. Role of Salival Beta-2 Microglogulin

    Janett Riega-Torres1, Amaury Valdés-Mancha2, Celia Sánchez-Domínguez3, Lorena Pérez-Barbosa1, Ana Arana-Guajardo4, David Vega-Morales5 and Mario Alberto Garza-Elizondo1, 1Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 2Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Departamento de Bioquímica, Facultad de Medicina. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 4Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 5Universidad Autónoma de Nuevo Léon, Monterrey, Mexico

    Background/Purpose: Sicca Syndrome patients represent a diagnostic challenge for the wide variety of etiologies that can afford it. Beta-2 Microglogulin (B2MG) is a non-glycosylated protein,…
  • Abstract Number: 672 • 2016 ACR/ARHP Annual Meeting

    Sjogren Big Data Project: Influence of Geolocation on the Phenotypic Expression at Diagnosis in 8310 Patients (North-to-South Gradient)

    Pilar Brito-Zerón1,2, Soledad Retamozo3, Margit Zeher4, Astrid Rasmussen5, Raphaele Seror6, Elke Theander7, Xiaomei Li8, Chiara Baldini9, Jacques-Eric Gottenberg10, Debashish Danda11, Luca Quartuccio12, Roberta Priori13,14, Gabriela Hernandez-Molina15, Aike A. Kruize16, Valeria Valim17, Marika Kvarnström18, Damien Sene19, Roberto Gerli20, Sonja Praprotnik21, David A. Isenberg22, Roser Solans23, Maureen Rischmueller24, Seung-Ki Kwok25, Gunnel Nordmark26, Yasunori Suzuki27, Roberto Giacomelli28, Valerie Devauchelle29, Michele Bombardieri30, Benedikt Hofauer31, Hendrika Bootsma32, Johan G. Brun33, Guadalupe Fraile34, Steven E. Carsons35, Tamer Gheita36, Jacques Morel37, Cristina F. Vollenweider38, Fabiola Atzeni39, Nihan Acar-Denizli40, Ildike-Fanny Horvath4, Kathy Sivils5, Thomas Mandl41, Pulukool Sandhya11, Salvatore De Vita42, Jorge Sánchez-Guerrero43, Eefje van der Heijden16, Virginia Moça Trevisano44, Marie Wahren-Herlenius18, Xavier Mariette6, Manuel Ramos-Casals1,45,46 and EULAR-SS Task Force Big Data Consortium (ASSES, GEAS-SEMI, EULAR), 1Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 2Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain, 3Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Argentina, Córdoba, Argentina, 4Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Debrecen, Hungary, 5Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, USA, Oklahoma City, OK, 6Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France, Paris, France, 7Department of Rheumatology, Malmö University Hospital, Lund University, Sweden, Malmö, Sweden, 8Department of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial Hospital, China, Hefei, Anhui, China, 9Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 10Department of Rheumatology, Strasbourg University Hospital, Université de Strasbourg, CNRS, Strasbourg, France, Strasbourg, France, 11Clinical Immunology & Rheumatology, Christian Medical College, Vellore, India, Vellore, India, 12Rheumatology Clinic, DSMB, University of Udine, Udine, Italy, Udine, Italy, 13Rheumatology Unit, Sapienza University of Rome, Rome, Italy, 14Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, 15Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico City, Mexico, 16Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands, Utrecht, Netherlands, 17Rheumatology, Department of Medicine, Universidade Federal do Espírito Santo, Vitória, Brazil, Vitória, Brazil, 18Department of Medicine, Solna, Unit of Experimental Rheumatology, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 19Service de Médecine Interne 2, Hôpital Lariboisière, Université Paris VII, Assistance Publique-Hôpitaux de Paris, 2, Paris, France, Paris, France, 20Clinical and Experimental Medicine, Rheumatology Unit, University of Perugia, Italy, Perugia, Italy, 21Department of Rheumatology, University Medical Centre Ljubljana, Slovenia, Ljubljana, Slovenia, 22Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom, 23Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, 24Department of Rheumatology, School of Medicine, The University of Western Australia, Crawley, Australia, Crawley, Australia, 25Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, South Korea, 26Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden, 27Division of Rheumatology, Kanazawa University Graduate School of Medicine, Ishikawa, Japan, Kanazawa, Japan, 28Clinical Unit of Rheumatology, University of l'Aquila, School of Medicine, L'Aquila, Italy, L'Aquila, Italy, 29Service de Rhumatologie, Department of Rheumatology, Brest University Hospital, Brest, France, Brest, France, 30Willian Harvey Research Institute, Centre for Experimental Medicine and Rheumatology, QMUL, UK, London, United Kingdom, 31Hals-Nasen-Ohrenklinik und Poliklinik, Technische Universität München, München, Germany, München, Germany, 32Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands, 33Department of Clinical Science, University of Bergen. Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, Bergen, Norway, 34Department of Internal Medicine, Hospital Ramón y Cajal, Madrid, Spain, Madrid, Spain, 35Division of Rheumatology, Allergy and Immunology Winthrop-University Hospital, Stony Brook University School of Medicine, NY, USA, Mineola, NY, 36Rheumatology, Rheumatology Department, Faculty of Medicine, Cairo University, Egypt, Cairo, Egypt, 37Department of Rheumatology, Teaching hospital and University of Montpellier, France, Montpellier, France, 38Rheumatology, German Hospital, Buenos Aires, Argentina, Buenos Aires, Argentina, 39IRCCS Galeazzi Orthopedic Institute, Milan, Italy, Milan, Italy, 40Department of Statistics, Faculty of Science and Letters, Mimar Sinan Fine Arts University, Turkey, Istabul, Turkey, 41Department of Clinical Sciences Malmö, Lund University, Skåne University Hospital, Rheumatology, Malmö, Sweden, Malmö, Sweden, 42Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital "Santa Maria della Misericordia", Udine, Italy, Udine, Italy, 43Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Mexico, 44Federal University of São Paulo, Sao Paulo, Brazil, San Paulo, Brazil, 45Sjögren Syndrome Research Group (AGAUR), Barcelona, Spain, 46Department of Medicine, University of Barcelona, Barcelona, Spain., Barcelona, Spain

    Background/Purpose: To analyse the influence of geolocation (North-to-South gradient) on the clinical presentation of primary Sjögren syndrome (SjS) at diagnosis. Methods: The Big Data Sjögren…
  • Abstract Number: 673 • 2016 ACR/ARHP Annual Meeting

    Sjögren’s Syndrome (SS): The Role of Traditional (SS-A/SS-B) and Novel Antibodies in Diagnosis

    Mohammed Bari1, Anam Shaikh2, Valerie Comissiong1, Bivin Varghese2 and Steven E. Carsons2, 1Department of Medicine, Winthrop-University Hospital, Stony Brook University School of Medicine, Mineola, NY, 2Division of Rheumatology, Allergy and Immunology Winthrop-University Hospital, Stony Brook University School of Medicine, NY, USA, Mineola, NY

    Background/Purpose: Diagnosing SS is often challenging, particularly distinguishing patients with primary SS from xerostomia and xerophthalmia (sicca). Recently, an IL-14 transgenic murine model led to…
  • Abstract Number: 674 • 2016 ACR/ARHP Annual Meeting

    Targeting Glandular IL-21-Production in Primary Sjogren′s Syndrome Patients By Immunomodulatory Treatment

    Gwenny M. Verstappen1, Hendrik L.F. Broekman1, Erlin A. Haacke2, Petra M. Meiners3, Fred K.L. Spijkervet3, Arjan Vissink4, Hendrika Bootsma5 and Frans G.M. Kroese1, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, The Netherlands, Groningen, Netherlands

    Background/Purpose:  Interleukin-21 plays a central role in plasma cell differentiation and germinal center (GC) formation and is likely involved in the pathogenesis of primary Sjögren’s…
  • Abstract Number: 675 • 2016 ACR/ARHP Annual Meeting

    Association Between Structural Lesions in the Sacroiliac Joints and Spinal Inflammatory Lesions in Patients with Non-Radiographic Axial Spondyloarthritis

    Maxime Dougados1, Robert G Lambert2, Stephanie Wichuk3, Jean-Claude Becker4, Jack F Bukowski5, Heather Jones6, Lisa Marshall6, Annette Szumski7 and Walter Maksymowych3, 1Rheumatology, Paris Descartes University, Paris, France, 2Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, 3Medicine, University of Alberta, Edmonton, AB, Canada, 4Becker Clinical Research Consulting, New York, NY, 5Clinical Affairs, Pfizer, Collegeville, PA, 6Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 7inVentiv Health, Princeton, NJ

    Background/Purpose: The relevance of structural lesions in non-radiographic axial SpA (nr-axSpA) is unclear, particularly without signs of MRI inflammation. In a post hoc analysis we…
  • Abstract Number: 676 • 2016 ACR/ARHP Annual Meeting

    Syndesmophytes in the Thoracic Spine in Ankylosing Spondylitis As Detected By Computed Tomography and Association with Lumbar Radiographic Involvement

    Sovira Tan and Michael Ward, NIAMS/NIH, Bethesda, MD

    Background/Purpose: Because the thoracic spine has traditionally been excluded from radiographic examinations of spinal damage in ankylosing spondylitis (AS) due to poor visualization, little is…
  • Abstract Number: 677 • 2016 ACR/ARHP Annual Meeting

    Low Functional Relevance of Radiographic Spinal Progression in Patients with Early Axial Spondyloarthritis

    Denis Poddubnyy1, Hildrun Haibel1, Jürgen Braun2, Martin Rudwaleit3 and Joachim Sieper1, 1Charité Medical University, Berlin, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany

    Background/Purpose: It has been shown in the past that radiographic spinal progression is an important determinant of the functional outcome in patients with advanced axial…
  • Abstract Number: 678 • 2016 ACR/ARHP Annual Meeting

    Additional Information from CT or MRI Imaging Can Increase Rheumatologists’ Consensus on Grading Sacroiliitis By Radiography: Results of the Trimage Project

    Nigil Haroon1, Xenofon Baraliakos2, Anne Grethe Jurik3, Gercek Can4, Ali Balcı5, Muhammet Cinar6, Ediz Dalkilic7, Salim Donmez8, Omer Nuri Pamuk9, Yavuz Pehlivan10, Salih Pay11, Handan Yarkan12, Gokce Kenar13 and Nurullah Akkoc13, 1Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3Department of Radiology, Aarhus University Hospital, Aarhus, Denmark, 4Department of Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 5Radiology, Dokuz Eylul University, Izmir, Turkey, 6Division of Rheumatology, Gülhane Military Medical Academy, School of Medicine, Ankara, Turkey, 7Department of Rhematology, Uludag University Faculty of Medicine, Bursa, Turkey, 8Department of Rheumatology, Trakya University Faculty of Medicine, Edirne, Turkey, 9Rheumatology, Trakya University Faculty of Medicine, Edirne, Turkey, 10Rheumatology, Uludag University Medcal Faculty, Bursa, Turkey, 11Rheumatology, Yüksek Ihtisas University, Special Koru Hospital, Ankara, Turkey, 12Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, 13Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

    Background/Purpose:  The diagnosis of ankylosing spondylitis (AS) is anchored on definitive changes of sacroiliits by radiography. This is relevant not only to clinical diagnosis, but…
  • « Previous Page
  • 1
  • …
  • 1460
  • 1461
  • 1462
  • 1463
  • 1464
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology